PTGS2 and breast cancer: By developing a COX2 over-expressing mammary cancer cell line (TM40D-COX2), we now provide evidence that metastasis can be exacerbated through variable COX2/PGE2 expression, potentially explained by a PGE2-induced Treg recruitment to the tumor, and subsequent induction of CD8+ T cell apoptosis.